Pharsight

CL BIOSCIENCES LLC patents facing oppositions

Top patents of CL BIOSCIENCES LLC facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3071206B1 17 Feb, 2021 Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis Nov, 2034 1